Population aging is rapidly becoming one of the most pressing challenges facing modern societies. In both developed and developing countries, life expectancy has increased while birth rates have declined, creating demographic structures that place increasing pressure on healthcare systems, pension models, and long-term economic sustainability.
As societies age, the prevalence of chronic diseases increases, labor force participation declines, and public spending related to age-related conditions continues to expand. According to various demographic projections, the proportion of people over 65 is expected to reach unprecedented levels in the coming decades, transforming aging from a private biological matter into a major social and economic issue.
In this context, a growing number of researchers are questioning whether aging should continue to be treated as an immutable fact of life or as a biological process that can be better understood—and potentially influenced—through scientific intervention. Aging researchers from around the world, like Marcos Arrut, are advocating for a rethinking of the issue.
“People generally talk about aging as something we should adapt to socially, when in reality it is a biological phenomenon that can be modulated,” stated Arrut, CEO of RenovaCode Therapeutics. He argues that aging exhibits characteristics of regulated biological systems, rather than mere stochastic degradation, and points out that there are mechanisms for controlling gene expression that would allow for its modulation.
Recent advances in epigenetics and cellular reprogramming have reinforced this perspective. Experimental research has shown that cells retain a form of regulatory memory that can be modified under specific conditions, leading to the restoration of youthful gene expression patterns. While these findings are still largely in the preclinical phase, they challenge the assumption that aging is a unidirectional process.
Researchers like Arrut have been involved in research initiatives exploring gene regulation and epigenetic control. “If aging is governed by genetic networks, then its progression is not inevitable. It is a phenomenon that we can modulate, delay, and even reverse,” he explained. This becomes a technical and strategic problem, with consequences for healthcare systems, economic productivity, and long-term planning.
Economists and policymakers are increasingly warning that current social structures were not designed for populations in which a large segment remains biologically aged for extended periods. Without fundamental changes, population aging could overburden public resources and limit economic dynamism.
As global demographics continue to change, perspectives that connect biology, economics, and long-term social stability are likely to become increasingly relevant in debates about the future of human health and longevity.
Beyond the scientific debate, the question of aging increasingly intersects with ethics, governance, and long-term societal design. If biological aging proves to be controllable, societies will be forced to confront difficult decisions regarding access, regulation, and the distribution of extended healthspan. These challenges extend well beyond laboratories and biotech companies, touching core assumptions about work, retirement, intergenerational contracts, and economic planning.
However, it is important to note that the transition from experimental models to safe human interventions remains complex. Nevertheless, the growing body of evidence suggesting that aging is regulated continues to undermine the long-held notion that it is simply an inevitable consequence of the passage of time.
As voices like Marcos Arrut contribute to this shift, the discussion around aging is gradually moving from resignation toward strategic consideration. Whether or not biological age can be meaningfully altered at scale, the reframing of aging as a modifiable process may itself prove consequential—reshaping how societies prepare for the demographic realities of the 21st century.
